Christopher Lieu, MD
Articles
Dr. Lieu Discusses the Focus of Future Research in mCRC
September 12th 2019Christopher Lieu, MD, director, GI Medical Oncology Program and deputy associated director for clinical research, at the University of Colorado Cancer Center, discusses where future research should focus in metastatic colorectal cancer.
Read More
Dr. Lieu Discusses the Rationale for Combined MEK/VEGF/PD-1 Inhibition in CRC
August 8th 2019Christopher Lieu, MD, director, GI Medical Oncology Program and deputy associated director for clinical research, at the University of Colorado Cancer Center, discusses the rationale for combined MEK, VEGF, and PD-1 inhibition in microsatellite stable (MSS) colorectal cancer (CRC).
Read More
Dr. Lieu on the Predictive Value of BRAF V600E Mutations in mCRC
July 26th 2019Christopher Lieu, MD, director, GI Medical Oncology Program and deputy associate director for clinical research, at the University of Colorado Cancer Center, discusses the predictive value of BRAF V600E mutations in metastatic colorectal cancer (mCRC).
Read More
Dr. Lieu on Investigational Immunotherapy Strategies in mCRC
July 2nd 2019Christopher Lieu, MD, director, GI Medical Oncology Program and deputy associate director for clinical research, at the University of Colorado Cancer Center, discusses investigational immunotherapy strategies in metastatic colorectal cancer (mCRC).
Read More
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
